Page last updated: 2024-11-06

va 061

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

VA 061: a water-soluble radical initiator; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID88715
CHEMBL ID1995494
CHEMBL ID1741328
SCHEMBL ID148682
MeSH IDM0392601

Synonyms (45)

Synonym
NCI60_023856
NCI60_023855
2,2'-azobis[2-(2-imidazolin-2-yl)propane]
NSC668414 ,
1h-imidazole,2'-[azobis(1-methylethylidene)]bis[4,5-dihydro-
nsc-668414
azobis(n,n'-dimethylene isobutylamidine)
imidazole,2'-(azodiisopropylidene)bis[4,5-dihydro-
azobis-n,n'-dimethyleneisobutyroamidine
20858-12-2
2-(1-((1-(4,5-dihydro-1h-imidazol-2-yl)-1-methylethyl)diazenyl)-1-methylethyl)-4,5-dihydro-1h-imidazole
NCGC00014974
{2,2'-azobis[2-(2-imidazolin-2-yl)propane]dihydrochloride}
(e)-bis[1-(4,5-dihydro-1h-imidazol-2-yl)-1-methyl-ethyl]diazene
2-(1-((1-(4,5-dihydro-1h-imidazol-2-yl)-1-methylethyl)diazenyl)-1-methylethyl)-4,5-dihydro-1h-imidazole hydrochloride
NCI668414
NCISTRUC2_001102
NCISTRUC1_000704
NCGC00098074-01
bis[2-(4,5-dihydro-1h-imidazol-2-yl)propan-2-yl]diazene
1,2-bis(2-(4,5-dihydro-1h-imidazol-2-yl)propan-2-yl)diazene
t7s2yy6bdk ,
unii-t7s2yy6bdk
nsc 668414
1h-imidazole, 2,2'-(azobis(1-methylethylidene))bis(4,5-dihydro-
1h-imidazole, 2,2'-(1,2-diazenediylbis(1-methylethylidene))bis(4,5-dihydro-
va 061
2,2'-(azodiisopropylidene)bis(4,5-dihydro-1h-imidazole)
einecs 244-085-4
CCG-38150
NCGC00014974-02
FT-0689248
1h-imidazole, 2,2'-[azobis(1-methylethylidene)]bis[4,5-dihydro-
AKOS015853582
SCHEMBL148682
DTXSID0066662
LWMFAFLIWMPZSX-UHFFFAOYSA-N
CHEMBL1995494
CHEMBL1741328
2,2-azobis[2-(2-imidazolin-2-yl)propane]
va-061
AKOS030228348
1h-imidazole, 2,2'-[1,2-diazenediylbis(1-methylethylidene)]bis[4,5-dihydro-
azo initiator va-061
2,2'-[1,2-diazenediylbis(1-methylethylidene)]bis[4,5-dihydro-1h-imidazole]
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID1224817Assays to identify small molecules inhibitory for eIF4E expression2015Chemistry & biology, Jul-23, Volume: 22, Issue:7
Internal Ribosome Entry Site-Based Bicistronic In Situ Reporter Assays for Discovery of Transcription-Targeted Lead Compounds.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (19)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's9 (47.37)29.6817
2010's6 (31.58)24.3611
2020's4 (21.05)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 20.94

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index20.94 (24.57)
Research Supply Index3.00 (2.92)
Research Growth Index4.64 (4.65)
Search Engine Demand Index18.60 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (20.94)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other19 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]